NDRA
ENDRA Life Sciences Inc. Common Stock
stockNASDAQ
endra life sciences is bringing new capabilities to ultrasound. our photo-acoustic solutions help medical researchers screen and modify disease models with unparalleled quality and speed. we're proud to have a global installed base of leading institutions using our nexus-128 system, the only 3d imaging solution for imaging anatomy, physiology and labeled molecular targets. the nexus 128 is a preclinical photoacoustic computed tomography (ct) scanner for small animal imaging. the system is used for simple, fast, non-invasive quantification of physiological parameters such as tumor vasculature without ionizing radiation. the fully-3d imaging technology used by the nexus 128 provides increased sensitivity compared to slice-based scanners, and dynamic (4-d) photoacoustic ct scans allow for applications such as quantification of probe uptake. the nexus 128 is currently being used by top imaging laboratories around the globe.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 6.31 | 2026-10-05 | -18.54% | -5.447 |
| 1M | 5.62 | 2026-09-11 | -8.54% | 3.632 |
| 3M | 5.50 | 2026-07-13 | -6.54% | 0.920 |
| 6M | 5.19 | 2026-04-13 | -0.96% | 1.800 |
| 1Y | 8.12 | 2025-10-13 | -36.70% | 1.022 |
| 2Y | 7.35 | 2024-10-11 | -30.07% | — |
| 5Y | 56,350.00 | 2021-10-12 | -99.99% | 1.159 |
ENDRA Life Sciences Inc. Common Stock (NASDAQ:NDRA) stock price today is $5.14, and today's volume is 15,120. NDRA is down 5.861% today. The 30 day average volume is 50,585. NDRA market cap is $7.71M with 1.50M shares outstanding.